New China Life Stock Current Valuation
| NCL Stock | EUR 2.84 0.02 0.71% |
Valuation analysis of New China Life helps investors to measure New China's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that New China's price fluctuation is dangerous at this time. Calculation of the real value of New China Life is based on 3 months time horizon. Increasing New China's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the New stock is determined by what a typical buyer is willing to pay for full or partial control of New China Life. Since New China is currently traded on the exchange, buyers and sellers on that exchange determine the market value of New Stock. However, New China's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.84 | Real 2.18 | Hype 2.84 | Naive 2.48 |
The real value of New Stock, also known as its intrinsic value, is the underlying worth of New China Life Company, which is reflected in its stock price. It is based on New China's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of New China's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of New China Life helps investors to forecast how New stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of New China more accurately as focusing exclusively on New China's fundamentals will not take into account other important factors: New China Life Company Current Valuation Analysis
New China's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current New China Current Valuation | 10.38 B |
Most of New China's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New China Life is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, New China Life has a Current Valuation of 10.38 B. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The current valuation for all Germany stocks is notably lower than that of the firm.
New China Life is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Other industry is now estimated at about 14.92 Billion. New China totals roughly 10.38 Billion in current valuation claiming about 70% of all equities under Other industry.New Fundamentals
| Current Valuation | 10.38 B | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 0.24 X | |||
| Revenue | 222 B | |||
| Net Income | 14.95 B | |||
| Total Debt | 10 B | |||
| Cash Flow From Operations | 73.85 B | |||
| Price To Earnings To Growth | 1.01 X | |||
| Number Of Employees | 45 | |||
| Market Capitalization | 13.89 B | |||
| Total Asset | 1.13 T | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.27 % | |||
| Net Asset | 1.13 T | |||
| Last Dividend Paid | 0.88 |
About New China Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New China Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New China using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New China Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in New Stock
New China financial ratios help investors to determine whether New Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in New with respect to the benefits of owning New China security.